Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dronabinol - Bionorica SE

Next Previous
Search
Drug Profile

Dronabinol - Bionorica SE

Alternative Names: BX-1

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bionorica
  • Class Antidementias; Antiemetics; Antineoplastics; Appetite stimulants; Cannabinoids; Chromans; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Chemotherapy-induced damage; Spasm
  • Phase II Post-traumatic stress disorders

Most Recent Events

  • 30 Mar 2021 Bionorica completes a phase III trial in Spasm (In the elderly, Treatment-experienced, In adults) in Czech Republic, Poland, Germany, Hungary and Spain (PO) (NCT03756974)
  • 01 Oct 2020 Phase-II clinical trials in Post-traumatic stress disorders in Germany (PO) (NCT04448808)
  • 26 Jun 2020 Bionorica SE in collaboration with Charite University plans a phase II trial for Posttraumatic stress disorders (In adults, In elderly) (PO) in Germany in June 2020 (NCT04448808)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top